Ignite Creation Date:
2024-05-06 @ 7:32 PM
Last Modification Date:
2024-10-26 @ 3:08 PM
Study NCT ID:
NCT06043921
Status:
RECRUITING
Last Update Posted:
2023-09-21
First Post:
2023-09-06
Brief Title:
Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel
Sponsor:
Organization:
Invitae Corporation
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Patients who have been diagnosed with pancreatic cancer and who have formalin-fixed paraffin-embedded FFPE tissue available will provide FFPE and whole-blood samples for the initial testing Blood samples will be collected for additional ctDNA monitoring samples using the Invitae Personalized Cancer MonitoringTM test Blood samples will be stored at Invitae MetroPark and may be used for future research
Enrollment Count:
150
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 99259 |
Who Masked List: